NASDAQ · QFIN

Qfin Holdings, Inc.. American

$13.56 +$0.37 (+2.81%) 1D After hours

Key Metrics

$1.61B
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow $1.55B
Beta · 1Y 1.04
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 10
    The stock moved -11.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 10
  • May 27
    The stock moved +25.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 27
  • May 22
    From its Feb 10 high, the share price fell 30%.

    Peak close $16.53 on Feb 10; trough close $11.65 on May 22. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -30%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.61B
Enterprise value
Shares outstanding121.8M
52-wk range$11.31 – $36.09
Avg volume · 20D1.6M
Net cash
Book value / share$28.32
ExchangeNASDAQ
About Qfin Holdings, Inc.. American
IPO dateDec 14, 2018
Employees3557

Qfin Holdings Inc is engaged in matching individual borrowers with credit demand to a diversified pool of financial institutions with credit to supply through a financial technology platform.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF1.04
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio2.43
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$4.16B

Cash Flow · TTM

Operating CF $1.58B
Capex −$34.40M
Free cash flow $1.55B
Buybacks $693.27M
Dividends paid
Shareholder yield 43.2%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings